CSF Proteomes Distinguish Lyme Disease from Chronic Fatigue Syndrome
Author Information
Author(s): Schutzer Steven E., Angel Thomas E., Liu Tao, Schepmoes Athena A., Clauss Therese R., Adkins Joshua N., Camp David G. II, Holland Bart K., Bergquist Jonas, Coyle Patricia K., Smith Richard D., Fallon Brian A., Natelson Benjamin H.
Primary Institution: University of Medicine and Dentistry of New Jersey-New Jersey Medical School
Hypothesis
Can cerebrospinal fluid (CSF) proteomes differentiate between post-treatment Lyme disease syndrome (nPTLS) and chronic fatigue syndrome (CFS)?
Conclusion
The study found that nPTLS and CFS have distinct CSF protein profiles, which can aid in developing diagnostics and treatments.
Supporting Evidence
- CFS had 2,783 non-redundant proteins, nPTLS contained 2,768 proteins, and healthy normals had 2,630 proteins.
- The study identified approximately 30,000 peptides corresponding to the proteins in the CSF samples.
- Pathway analysis indicated potential mechanisms underlying CFS and nPTLS.
Takeaway
Doctors can tell the difference between two illnesses, Lyme disease and chronic fatigue syndrome, by looking at the proteins in the fluid around the brain.
Methodology
The study analyzed pooled and individual CSF samples from nPTLS patients, CFS patients, and healthy controls using mass spectrometry.
Potential Biases
Potential biases may arise from the selection of patient samples and the reliance on specific diagnostic criteria.
Limitations
The study relied on previously banked de-identified samples, which may limit the generalizability of the findings.
Participant Demographics
CFS patients (n=43) were aged 18-54 (median 43), and nPTLS patients (n=25) were aged 17-64 (median 48), with a mix of genders.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website